2026 Poster Presentations
Preliminary List as of 6 October. We are expecting a lot more, so please check back.
2bind GmbH
A Screening Platform to Find a Cure for Ebola
ACROBiosystems
Integrated Strategies for Producing Functional Recombinant Proteins to Advance Autoimmune Disease Therapeutics
Adimab LLC
A Comprehensive Developability Panel for Accelerating Antibody Development into the Clinic with a Selective and Highly Predictive Set of Assays
Alcyomics Ltd.
Skimune®: A Powerful Human-Centric Platform for the Identification of T Cell Engager Immunotoxicity
Alloy Therapeutics
High Velocity Approach to Antibody Discovery and Optimization Using AI-Enabled and ML-Powered In Silico Workflows Combined with High-Throughput Expression and Testing
Araris Biotech AG
ARC-401, a Triple Payload First-in-Class ADC Against Nectin-4 Designed to Overcome Cancer Resistance and Tumor Heterogeneity, Shows Broad Anti-Tumor Activity and High Tolerability in Relevant Animal Models
AstraZeneca
Diversity that Delivers: Structurally Designed Libraries Powering Peptide Binder Discovery
AVS Bio
Amplifying the Therapeutic Potential of Rabbit-Derived Antibodies by an Advanced, Multi-Parametric Humanization Approach for Single-Step Engineering
AVS Bio
Boosting Diversity-Focused Lead Antibody Generation by In Silico-Guided Rare Hit Magnification and Epitope-Driven Affinity Finetuning
Axxam S.p.A.
An Integrated Workflow for Accelerated VHH Identification and Characterization with High-Throughput Functional Assays: A Comprehensive Case Study on CDK2/CycE1 Complex
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
BCG015: A First-in-Class Antibody-Drug Conjugate Targeting TM4SF5 for the Treatment of Hepatocellular Carcinoma
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
CRB2104: A 2:1 AMHR2/CD3 T Cell Engager Targeting AMHR2-Positive Solid Tumors
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Novel Blood-Brain Barrier Penetrating Heavy Chain-Only Antibodies Targeting CD98
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
RenSuper Workstation™: An AI-Powered, Closed-Loop In Vivo Discovery and Automation Engine for High-Efficiency Therapeutic Antibody Generation Infrastructure
BOKU - University of Natural Resources and Life Sciences
Understanding the Influence of Protein Surface Mutations on Expressibility: Variant Library Analysis with Explainable AI
Boldrini Research Center
A Humanized NBSGW Mouse Platform for In Vivo Evaluation of a Humanized Anti-IL-7Ralpha Antibody in Pediatric Leukemia
Bruker Cellular Analysis
Single-Cell Function Driven Screening and Characterization of Bispecific T Cell Engagers
Bruker Dynamic Biosensors
Integrated Biophysical Analysis of Fc–FcR Binding, Affinity, and Avidity in Antibody Therapeutics
Carterra, Inc.
Accelerating the Discovery of Therapeutic Antibodies Using High Throughput SPR
Carterra, Inc.
Strategies for Scalable and Sensitive Determination of High Affinity and Slow Dissociating Binding Interaction Kinetics in Antibody Discovery
Chemical Computing Group
Pharmacophore-Guided Virtual Screening of Antibody Formats
Chemical Computing Group
Structure-Based Charge Calculations for Predicting Properties and Profiling Antibody Therapeutics
Fusion Antibodies
OptiMAL®: Mammalian Display for Antibody Discovery
Genedata AG
A Digital Platform for the Development of Next-Generation Antibody Drug Conjugates (ADCs) and Other Antigen-Targeting Conjugates
Genedata AG
An Automated High Throughput Engineering Platform for AI-Supported Developability Predictions
Genedata AG
Ensuring Data Quality, Traceability, and Interpretability with Automated Assay Data Workflows
Genedata AG
In-Depth Characterization of Antibody-Drug Conjugates by Subunit-Level Mass Spectrometry
Genedata AG
Smart Analysis of Experimental Context and Accelerated Biologics Lead Optimization Through AI-Guided Developability Workflows in Hit Profiler
iBET - Instituto de Biologia Experimental e Tecnológica
Cognate-Chain Expression Imbalance Drives Half-Antibody and Homodimer Mispairing in a Transposase-Based CHO Platform for Bispecific Antibodies
Indian Institute of Technology, Madras
Pep_Dez: An AI-Guided Active Learning Framework for the Rapid Design of De Novo Peptide Disruptors of Protein-Protein Interactions
Integral Molecular
Antibodies Against 100+ Impossible Protein Targets: High-Quality mAbs for Previously Intractable GPCRs, Ion Channels and Transporters
Integral Molecular
Engineering GPRC5D Multispecific Antibodies: Parallel Engineering to Optimize Affinity, Developability, Species Reactivity, and IP
Integral Molecular
How Specific Are Antibody Therapeutics?: A Systematic Evaluation of Drugs Throughout Preclinical and Clinical Development
Kaneka Eurogentec SA
A Versatile Microbial Platform for Rapid GMP Manufacturing of VHH Antibodies
Kaohsiung Medical University
Combination of Lenalidomide and Dexamethasone with Pro-Anti-PD-1 Antibodies for Enhanced Safety and Efficacy in Multiple Myeloma Therapy
Kaohsiung Medical University
Innovative Antithrombotic and Cardiovascular Disease Therapeutic Strategy Through Development of a Specific Anti-PAR4 Monoclonal Antibody
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Impurity Profile-Guided Purification Strategy for Knobs-into-Holes Bispecific Antibodies
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Advancing Pancreatic Cancer Therapy by Mesothelin-Specific Nanobody Conjugation
KU Leuven
Increasing Brain Half-Life of Antibodies by Additional Binding to Myelin Oligodendrocyte Glycoprotein, a CNS Specific Protein
LiveDrop Bio
Accelerating Therapeutic Antibody Discovery with High-Throughput Droplet Microfluidics
LiveDrop Bio
From iPSCs to Immune Cells: High-Throughput Production and Single-Cell Functional Analysis with Droplet Microfluidics
Lonza
Demonstration of Lonza’s Intensified Fed-Batch for Multiple Products and Scales
Mabylon AG
Engineering Multispecific Antibody Therapeutics for Allergy Prevention
National Research Council Canada & Polytechnique Montreal
Designing Coil-Functionalized Antibodies with Preserved Manufacturability for the Generation of Antibody-Drug Conjugates
Nexus BioQuest
Bridging the Translational Gap: In Vitro Platforms for Assessing Therapeutic Depletion Mechanisms
Nona Biosciences
Developing a Fully Human CD19 T Cell Engager Using Nona HBICE Platform
Nona Biosciences
Fully Human HACb Antibody Discovery Enhanced by Hu-mAtrIx AI-Integrated Platform
Novartis Pharma AG
Optimizing Antigen-Expressing Stable Cell Line Development Using Transposases
Nuclera
Cell-Free–Produced Antibodies Match CHO for Binding Assessment
Nuclera
From DNA to Active, Monomeric β1AR Receptor in <72 Hours Using Cell-Free Synthesis
OmniAb
Development of OmniUltra™: A Transgenic Chicken System for the Generation of Ultralong CDRH3 Antibodies, Mini-Proteins, and Structured Peptides
Protein Metrics by Dotmatics
Antibody and Therapeutics Discovery: Validating Multi-Dataset Enrichment Analysis Against a Published Phage Display Campaign
Protein Metrics by Dotmatics
Automated, High-Throughput Screening of Complex Biologics
Protein Metrics by Dotmatics
Progressive Deconvolution Provides Robust Feature Detection and Quantitation for Large Mass Intact MS Analyses
Sanofi
A Computational Design Strategy for Biologics Engineering
SCIEX
Enhancing Protein Purity Analysis Using CE-SDS with Native Fluorescence Detection
SPECIFICA, an IQVIA business
Advancing Antibody Developability Assessment: Integrating Gen3 Discovery with Orthogonal Polyreactivity Screening Approaches
SunBio, Inc.
Sustained Uric Acid-Lowering Activity of CanopyPEG-Uricase Compared with Conventional mPEG-Uricase Following Repeated Administration
Technische Universität Darmstadt
Bispecific GM-CSF Mimetics Resistant to Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patient-Derived Anti-GM-CSF Autoantibody Responses
Technische Universität Darmstadt
Discovery of TCRm-Antibodies Targeting PRAME[245-433] from a Chicken scFv Library
Technische Universität Darmstadt
Targeted Therapeutics: Antibody functionalized LNPs for the Treatment of Ovarian Cancer
Technische Universität Darmstadt
Trispecific Antibody Drug Conjuagtes for Cancer Therapy
Thermo Fisher Scientific
Redefining Clarification: Chromatographic Approaches for High-Density Bioprocessing
Twist Bioscience
Accelerating Multispecific Antibody Discovery and Development. Robust, Easy to Access, Industry-Leading Bispecific Platform
Twist Bioscience
Antibody Discovery from Immune VHH Library Using Yeast Surface Display
Twist Bioscience
Express Screening Antibodies: SPR Data from Cell Free IgG. Expression as Few as 5 Business Days
Universidade Estadual de Campinas (UNICAMP)
Development of a Stable Cell Line Producing Anti-IL7R Antibodies by Site-Specific Integration
Universidade Estadual de Campinas (UNICAMP)
Elucidating the Anti-Leukemic Mechanism of a Novel Anti-IL7Ra Antibody in Pediatric Leukemia
Universidade Estadual de Campinas (UNICAMP)
Targeting IL7Ra with a Humanized Monoclonal Antibody: Therapeutic Potential in B- and T-Acute Lymphoblastic Leukemia
Università degli Studi di Siena
Development of Antibody-Antimicrobial Conjugates (AAC) to Combact Infectious Diseases
University of Chicago
PeptiForge: Rapid, High-Quality Discovery of Peptide and Protein Binders
University of Huddersfield
Biophysical Profiling of Biosurfactants for Protein and Peptide Stability in Biologic Formulations
University of Michigan
Germline-Guided Redesign of Therapeutic Antibodies to Co-Optimize Developability and Affinity
Vect-Horus
Distinct Geometries, Comparable Interfaces: Binding Modes and Thermodynamic Implications in Conventional and Single Domain Antibodies
VERAXA Biotech GmbH
A Conditionally Active T Cell Engager Platform Enabled by Split-CD3 Engineering
Vysens B.V.
Multipurpose Cell Avidity Measurements Using the CellVysion SPR Imaging Platform
Vysens B.V.
Multi-Specific Engagement Studies with World’s First Cell Avidity SPR Imaging Platform: The CellVysion
WuXi Biologics
Mechanism-Guided In Vitro Characterization of Antibody-Drug Conjugates for Candidate Optimization and Differentiation
WuXi Biologics
MOA-Guided In Vivo Pharmacology Characterization of T Cell Engagers Using Complementary NHP and Murine Models to Support Translational Assessment